Mika K. Derynck

2.7k citations
34 papers · 1.5k indexed · h-index 15
Topics
Monoclonal and Polyclonal Antibodies Research (14 papers)HER2/EGFR in Cancer Research (9 papers)CAR-T cell therapy research (8 papers)

In The Last Decade

Mika K. Derynck

34 papers receiving 1.4k citations

Peers

Mika K. Derynck
Comparison fields: 5 of 92
  • Molecular Biology 648
  • Oncology 553
  • Genetics 331
  • Pulmonary and Respiratory Medicine 308
  • Cancer Research 281
Replace Svetlana Bajalica‐Lagercrantz with:
Svetlana Bajalica‐Lagercrantz Sweden
Erling A. Høivik Norway
Corinne M. Silva United States
Cecilia J. Proietti Argentina
Nicole S. Spoelstra United States
Lydia W.T. Cheung Hong Kong
Caroline H. Diep United States
Dawn R. Cochrane United States
Erika Krasnickas Keeton United States
Matthew H. Herynk United States
Mika K. Derynck relative to Svetlana Bajalica‐Lagercrantz Sweden Svetlana Bajalica‐Lagercrantz's profile →
Citations per field
00.5×1.5×
Svetlana Bajalica‐Lagercrantz · 1×
Citations per year

Countries citing papers authored by Mika K. Derynck

Since Specialization
Citations

This map shows the geographic impact of Mika K. Derynck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mika K. Derynck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mika K. Derynck more than expected).

Fields of papers citing papers by Mika K. Derynck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mika K. Derynck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mika K. Derynck. The network helps show where Mika K. Derynck may publish in the future.

Co-authorship network of co-authors of Mika K. Derynck

This figure shows the co-authorship network connecting the top 25 collaborators of Mika K. Derynck. A scholar is included among the top collaborators of Mika K. Derynck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mika K. Derynck. Mika K. Derynck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 50
2 1
3 4
4 1
5 4
6 1
7 16
8 219
9 2
10 8
11 53
12 24
13 19
14 187
15 7
16 90
17 257
18 4
19 72
20 204

About Mika K. Derynck

Mika K. Derynck is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 34 papers that have together received 1.5k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (14 papers), HER2/EGFR in Cancer Research (9 papers) and CAR-T cell therapy research (8 papers). The work is most often cited by research in Oncology (553 citations), Cancer Research (281 citations) and Reproductive Medicine (129 citations). Mika K. Derynck has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Daniel Khodabakhsh, Daisuke Nonaka, Keith R. Yamamoto, Jen-Chywan Wang, Chris Haqq, Christopher M. Haqq, Michael J. Garabedian, Inez Rogatsky, Beatrice Darimont and David E. Allison. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026